Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gemcitabine + Oxaliplatin in Inoperable Biliary Tract Adenocarcinoma
NCT00504192Phase 2Completed
- Sponsor
- Soonchunhyang University Hospital
- Start
- Sep 2006
- Primary completion
- Mar 2008
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of gemcitabine and oxaliplatin in biliary tract adenocarcinoma, sponsored by Soonchunhyang University Hospital. Primary endpoint: Overall Response Rate. Started Sep 2006; status: completed.
02
Drugs
gemcitabineoxaliplatin
03
Conditions
biliary tract adenocarcinoma
Beyond the preview
Go deeper on NCT00504192.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00504192.